Cargando…

A new initiative for the development of new diagnostic tests for human African trypanosomiasis

Human African trypanosomiasis is a threat to millions of people living in sub-Saharan countries and is fatal unless treated. At present, the serological and parasitological tests used in the field for diagnosis of sleeping sickness have low specificity and sensitivity. There is clearly an urgent nee...

Descripción completa

Detalles Bibliográficos
Autor principal: Steverding, Dietmar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464096/
https://www.ncbi.nlm.nih.gov/pubmed/16638141
http://dx.doi.org/10.1186/1475-9292-5-1
_version_ 1782127534881636352
author Steverding, Dietmar
author_facet Steverding, Dietmar
author_sort Steverding, Dietmar
collection PubMed
description Human African trypanosomiasis is a threat to millions of people living in sub-Saharan countries and is fatal unless treated. At present, the serological and parasitological tests used in the field for diagnosis of sleeping sickness have low specificity and sensitivity. There is clearly an urgent need for accurate tools for both diagnosis and staging of the disease. The Foundation for Innovative New Diagnostics and the World Health Organization have announced that they will collaborate to develop and evaluate new diagnostic tests for human African trypanosomiasis.
format Text
id pubmed-1464096
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14640962006-05-20 A new initiative for the development of new diagnostic tests for human African trypanosomiasis Steverding, Dietmar Kinetoplastid Biol Dis Focus Human African trypanosomiasis is a threat to millions of people living in sub-Saharan countries and is fatal unless treated. At present, the serological and parasitological tests used in the field for diagnosis of sleeping sickness have low specificity and sensitivity. There is clearly an urgent need for accurate tools for both diagnosis and staging of the disease. The Foundation for Innovative New Diagnostics and the World Health Organization have announced that they will collaborate to develop and evaluate new diagnostic tests for human African trypanosomiasis. BioMed Central 2006-04-25 /pmc/articles/PMC1464096/ /pubmed/16638141 http://dx.doi.org/10.1186/1475-9292-5-1 Text en Copyright © 2006 Steverding; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Focus
Steverding, Dietmar
A new initiative for the development of new diagnostic tests for human African trypanosomiasis
title A new initiative for the development of new diagnostic tests for human African trypanosomiasis
title_full A new initiative for the development of new diagnostic tests for human African trypanosomiasis
title_fullStr A new initiative for the development of new diagnostic tests for human African trypanosomiasis
title_full_unstemmed A new initiative for the development of new diagnostic tests for human African trypanosomiasis
title_short A new initiative for the development of new diagnostic tests for human African trypanosomiasis
title_sort new initiative for the development of new diagnostic tests for human african trypanosomiasis
topic Focus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464096/
https://www.ncbi.nlm.nih.gov/pubmed/16638141
http://dx.doi.org/10.1186/1475-9292-5-1
work_keys_str_mv AT steverdingdietmar anewinitiativeforthedevelopmentofnewdiagnostictestsforhumanafricantrypanosomiasis
AT steverdingdietmar newinitiativeforthedevelopmentofnewdiagnostictestsforhumanafricantrypanosomiasis